Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa Reclamada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions leer más
teamwork, helping people, getting something done
¿Qué es lo más positivo de la cultura y el ambiente de tu empresa?
that it seems to be changing for the better
Revisión
¿Qué son algunas de las mejores cosas de tu equipo?
the good people on our team are the most collaborative I've ever worked with
Revisión
¿Por qué te sientes menospreciado y que podría hacerte sentir mejor sobre tu compensación?
seeing others who do less than me get promoted over me doesn't make me want to work harder, especially when that someone dumps their work on me
Revisión
Other Employee Reviews for Karyopharm Therapeutics
×